Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Short-term Investments: 2020-2023

Historic Short-term Investments for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $111.4 million.

  • Therapeutics' Short-term Investments fell 54.07% to $60.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $60.0 million, marking a year-over-year decrease of 54.07%. This contributed to the annual value of $111.4 million for FY2023, which is 46.99% down from last year.
  • Per Therapeutics' latest filing, its Short-term Investments stood at $111.4 million for FY2023, which was down 46.99% from $210.1 million recorded in FY2022.
  • In the past 5 years, Therapeutics' Short-term Investments registered a high of $210.1 million during FY2022, and its lowest value of $86.6 million during FY2020.
  • In the last 3 years, Therapeutics' Short-term Investments had a median value of $165.6 million in 2021 and averaged $162.4 million.
  • Per our database at Business Quant, Therapeutics' Short-term Investments skyrocketed by 91.27% in 2021 and then slumped by 46.99% in 2023.
  • Yearly analysis of 4 years shows Therapeutics' Short-term Investments stood at $86.6 million in 2020, then soared by 91.27% to $165.6 million in 2021, then increased by 26.86% to $210.1 million in 2022, then tumbled by 46.99% to $111.4 million in 2023.